Discover what's new.

Access the latest news, business developments, company updates, industry trends, events and more.

| By Caitlin Truesdale

Colleges have $16.5 billion impact on Connecticut

The economic impact on the State of Connecticut from its fifteen non-profit independent colleges and universities  is $16.5 billion annually, according to a just completed study...

| By Caitlin Truesdale

‘Power 25’ celebrates New Haven area leaders

The newhavenbiz annual Power 25 list features individuals based in the Greater New Haven region who hold significant influence within their organizations and the broader business community....

| By Caitlin Truesdale

The Roundup – March 2, 2023

View this email in your browser March 2, 2023 Alexion Pharmaceuticals is committed to working with the patient community and health care stakeholders worldwide to address...

| By Caitlin Truesdale

CYduct Diagnostics wins breast cancer grant

CYduct Diagnostics recently won a prestigious grant award for their work within breast cancer risk assessment. The grant, generously awarded by the Sharon D. Lund Foundation,...

| By Caitlin Truesdale

Hyperfine software update approved by FDA

Guilford-based Hyperfine reports it has secured FDA approval of a software update for its portable MRI device that will boost its image quality and accuracy. With the...

| By Caitlin Truesdale

Biohaven wins fast track approval for spinal drug

New Haven’s Biohaven has earned FDA “Fast Track” designation for its drug to treat muscle loss in spinal muscular atrophy patients. Biohaven’s drug,  taldefgrobep alfa, is scheduled...

| By Caitlin Truesdale

Lumendi receives clearance for two new devices

Lumendi reports that it has received FDA 510(k) clearance for DiLumen EZ¹, a single-use, disposable endotherapy device for endoscopic mucosal resections (EMR) and difficult colonoscopies. The new,...

| By Caitlin Truesdale

Cybrexa names additions to management team

Cybrexa Therapeutics has reported the appointments of Laurie Kenvin as Vice President of Clinical Operations and Nick Saccomano, Ph.D., to the Company’s Scientific Advisory Board (SAB). “We...

| By Caitlin Truesdale

February 23, 2023 Should Health Care & Life Sciences Care About IRS Section 174? If you are a taxpayer and have research and experimental (R&E)...

| By Caitlin Truesdale

Rallybio names Lieber Chief Financial Officer

Rallybio reports that Jonathan I. Lieber has joined the company as Chief Financial Officer, effective February 1. Mr. Lieber succeeds Jeffrey Fryer, CPA, Rallybio’s Co-Founder and...